SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001714899-20-000118
Filing Date
2020-11-05
Accepted
2020-11-05 16:28:22
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dnli-20200930.htm   iXBRL 10-Q 1977770
2 EX-10.1 exhibit101q32020.htm EX-10.1 267719
3 EX-10.2 exhibit102q32020.htm EX-10.2 451894
4 EX-10.3 exhibit103q32020.htm EX-10.3 92001
5 EX-10.4 exhibit104q32020.htm EX-10.4 873218
6 EX-10.5 exhibit105q32020.htm EX-10.5 694389
7 EX-10.6 exhibit106q32020.htm EX-10.6 165055
8 EX-31.1 exhibit311q32020.htm EX-31.1 9986
9 EX-31.2 exhibit312q32020.htm EX-31.2 9985
10 EX-32.1 exhibit321q32020.htm EX-32.1 5683
11 EX-32.2 exhibit322q32020.htm EX-32.2 5790
17 image_01a.jpg GRAPHIC 30648
  Complete submission text file 0001714899-20-000118.txt   10717858

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnli-20200930.xsd EX-101.SCH 55145
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dnli-20200930_cal.xml EX-101.CAL 71488
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dnli-20200930_def.xml EX-101.DEF 269811
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnli-20200930_lab.xml EX-101.LAB 627791
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnli-20200930_pre.xml EX-101.PRE 411224
18 EXTRACTED XBRL INSTANCE DOCUMENT dnli-20200930_htm.xml XML 1279858
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38311 | Film No.: 201290917
SIC: 2836 Biological Products, (No Diagnostic Substances)